Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy

Bendixen RM, Butrum J, Jain MS, Parks R, Hodsdon B, Nichols C, Hsia M, Nelson L, Keller KC, McGuire M, Elliott JS, Linton MM, Arveson IC, Tounkara F, Vasavada R, Harnett E, Punjabi M, Donkervoort S, Dastgir J, Leach ME, Rutkowski A, Waite M, Collins J, Bönnemann CG, Meilleur KG 
Neuromuscul Disord. 2017. 27(3):278-285.
 The goal of the study was to validate a battery of upper extremity measures in collagen VI-related muscular dystrophy and laminin alpha 2-related dystrophy.
All upper extremity measures were correlated with MFM scores.

PubMed link

Keywords: Collagen VI-related muscular dystrophy; Congenital muscular dystrophy; Laminin alpha 2-related dystrophy; QUEST, Jebsen, Motor Function Measure; Upper extremity measures

Articles dans les revues scientifiques

Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial

Bertini E, Dessaud E, Mercuri E, Muntoni F, Kirschner J, Reid C, Lusakowska A, Comi GP, Cuisset JM, Abitbol JL, Scherrer B, Ducray PS, Buchbjerg J, Vianna E, van der Pol WL, Vuillerot C, Blaettler T, Fontoura P; Olesoxime SMA Phase 2 Study Investigators Lancet Neurol....

read more